| |
Q0.50
| |
Q0.75
| |
|---|
| |
Days
|
P-value
|
Days
|
P-value
|
|---|
|
Intercept
|
7.28
|
0.89
|
15
|
0.08
|
|
Age at diagnosis
|
|
< 50
|
2.33
|
0.5
|
−0.96
|
0.92
|
|
50–59
|
4.85
|
0.09
|
3.39
|
0.58
|
|
60–69
|
0
|
.
|
0
|
.
|
|
70–79
|
5
|
0.0425
|
8.59
|
0.17
|
|
≥ 80
|
14.27
|
0.0001
|
34.28
|
0.0003
|
|
Residential Zones
|
|
Calgary
|
0
|
.
|
0
|
.
|
|
Central
|
3.18
|
0.33
|
9.23
|
0.25
|
|
Edmonton
|
−0.62
|
0.81
|
1.13
|
0.85
|
|
North
|
0.98
|
0.79
|
8.67
|
0.44
|
|
South
|
−7.15
|
0.0189
|
−15.33
|
0.0455
|
|
Anatomic site
|
|
Colon
|
6.47
|
0.0014
|
9.56
|
0.0536
|
|
Rectum
|
0
|
.
| | |
|
Stage at diagnosis
|
|
I
|
25.67
|
<.0001
|
42.13
|
<.0001
|
|
II
|
8.47
|
0.0013
|
14.03
|
0.031
|
|
III
|
11
|
<.0001
|
23.98
|
0.0001
|
|
IV
|
0
|
.
|
0
|
.
|
|
Charlson Comorbidity Score
|
|
0
|
0
|
.
|
0
|
.
|
|
1
|
5.13
|
0.0371
|
19.21
|
0.0025
|
|
≥ 2
|
31.86
|
<.0001
|
82.24
|
<.0001
|
|
GI comorbidity
|
|
No
|
6.4
|
0.0014
|
29.18
|
<.0001
|
|
Yes
|
0
|
.
|
0
|
.
|
|
Usual Provider Continuity
|
|
< 3 primary care visits
|
4.52
|
0.35
|
13.54
|
0.39
|
|
Low < =50%
|
5.47
|
0.07
|
18.34
|
0.0046
|
|
Medium 5080%
|
4.87
|
0.06
|
11.64
|
0.0269
|
|
High >80%
|
0
|
.
|
0
|
.
|
|
# of GP visits
|
|
0–1
|
0
|
.
|
0
|
.
|
|
2
|
44.13
|
<.0001
|
91.45
|
<.0001
|
|
≥ 3
|
140.8
|
<.0001
|
201.59
|
<.0001
|
|
# of GI specialist visits
|
|
0
|
0
|
.
|
0
|
.
|
|
1
|
33.46
|
<.0001
|
50.68
|
<.0001
|
|
≥ 2
|
108.54
|
<.0001
|
153.56
|
<.0001
|
|
# of non-GI specialist visits
|
|
0
|
0
|
.
|
0
|
.
|
|
≥ 1
|
81.55
|
<.0001
|
101.56
|
<.0001
|
|
# of endoscopy
|
|
0
|
17.44
|
<.0001
|
52.66
|
<.0001
|
|
1
|
0
|
.
|
0
|
.
|
|
≥ 2
|
36.05
|
<.0001
|
50.43
|
<.0001
|
- The unconditional percentiles corresponded to diagnostic interval cut-off values are Q0.50 = 79 and Q0.75 = 206 days
